Koninklijke Philips Ebitda Over Time
PHG Stock | USD 26.38 0.07 0.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Koninklijke Philips Performance and Koninklijke Philips Correlation. Koninklijke |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Koninklijke Philips. If investors know Koninklijke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Koninklijke Philips listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.069 | Earnings Share (0.51) | Revenue Per Share 19.75 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0136 |
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Koninklijke Philips' value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke Philips is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke Philips' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Koninklijke Philips and related stocks such as ZimVie Inc, Stryker, and Boston Scientific Corp Ebitda Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZIMV | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 116.1 M | 112.5 M | (86.7 M) | 28.7 M | 79.2 M | 91.1 M | 95.6 M |
SYK | 16.7 M | 2.3 B | 2.4 B | 1.7 B | 1.6 B | 2.9 B | 3 B | 3.3 B | 3.3 B | 3.9 B | 3.8 B | 4.6 B | 4.5 B | 5.2 B | 5.4 B |
BSX | 73.7 M | 2.1 B | 1.3 B | 1.3 B | 1.3 B | 1.4 B | 1.8 B | 2 B | 2.4 B | 2.1 B | 1.5 B | 2.5 B | 2.7 B | 3.5 B | 3.6 B |
STE | 400 K | 234.8 M | 208.1 M | 233.2 M | 226.4 M | 211.3 M | 344.7 M | 403.7 M | 473.4 M | 538.3 M | 800.3 M | 957.2 M | 1.3 B | 1.4 B | 1.5 B |
SNN | 148.1 M | 1.2 B | 1.2 B | 1.2 B | 1.3 B | 1.2 B | 1.3 B | 1.3 B | 1.4 B | 1.4 B | 839 M | 1.2 B | 1 B | 979 M | 792.8 M |
CNMD | 1.7 M | 111.3 M | 111.8 M | 104.4 M | 98.5 M | 95.1 M | 90 M | 105.5 M | 133.1 M | 73.9 M | 113.6 M | 158.4 M | 7.8 M | 182.2 M | 191.3 M |
GKOS | (21.5 M) | (21.5 M) | (21.5 M) | (13 M) | (8.9 M) | (10.2 M) | 5.1 M | 45 K | (6.7 M) | (47.5 M) | (83.6 M) | (1.5 M) | (48.8 M) | (82.1 M) | (78 M) |
ITGR | 22.5 M | 61.7 M | 24.9 M | 60.8 M | 76.5 M | 14.5 M | 203.8 M | 232.6 M | 243.8 M | 236.1 M | 207.6 M | 215.3 M | 215.4 M | 282.1 M | 296.2 M |
EW | 197 M | 316.9 M | 424.4 M | 387.2 M | (176.9 M) | 649.7 M | 885.4 M | 999.4 M | 1.4 B | 1.3 B | 1.1 B | 1.9 B | 2 B | 1.5 B | 1.6 B |
ABT | 837.4 M | 5.9 B | 8.4 B | 3.5 B | 3.1 B | 3.7 B | 2.8 B | 5 B | 6 B | 6.7 B | 8.8 B | 12.7 B | 12.4 B | 10.5 B | 11 B |
MDT | 80.1 M | 5.3 B | 6 B | 6.7 B | 6.2 B | 9.2 B | 9.6 B | 9.4 B | 9.7 B | 8.2 B | 8.2 B | 9.6 B | 8.5 B | 9.1 B | 4.7 B |
ZBH | 237 M | 1.5 B | 1.7 B | 1.7 B | 1.4 B | 1.9 B | 2.4 B | 2.8 B | 2.2 B | 2.3 B | 969.7 M | 2.2 B | 2.2 B | 2.4 B | 1.6 B |
BRKR | (161 K) | 158.6 M | 217.5 M | 238.1 M | 209.3 M | 228.6 M | 257.3 M | 298.3 M | 346.8 M | 383 M | 320.7 M | 497.1 M | 545.3 M | 599 M | 629 M |
BIO | 10.3 M | 416.1 M | 416.3 M | 329.4 M | 312.9 M | 309.6 M | 273.2 M | 289 M | 366.6 M | 390 M | 5.1 B | 5.6 B | (4.5 B) | (608.3 M) | (577.9 M) |
GMED | 99.2 M | 117.3 M | 131.3 M | 167.2 M | 171.4 M | 173.8 M | 202.9 M | 212.5 M | 226.1 M | 230 M | 178.3 M | 250.3 M | 304.5 M | 418.2 M | 219.4 M |
PODD | (12.7 M) | (27.9 M) | (24.9 M) | (17.3 M) | (74 K) | (32.8 M) | (9.9 M) | 6.5 M | 43.1 M | 50 M | 110.3 M | 139.6 M | 109.5 M | 323.6 M | 339.8 M |
INSP | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (19.7 M) | (17.1 M) | (15.5 M) | (18.5 M) | (31.1 M) | (53.2 M) | (38.6 M) | (39.7 M) | (40.3 M) | (42.3 M) |
NVCR | (68.5 M) | (68.5 M) | (68.5 M) | (68.5 M) | (78.2 M) | (100.8 M) | (109.7 M) | (31.7 M) | (24.7 M) | 7.5 M | 45.3 M | (34.1 M) | (78.9 M) | (175.9 M) | (167.1 M) |
NARI | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | (8.9 M) | 1.3 M | 16.4 M | 15.5 M | (18.3 M) | 7.1 M | 7.5 M |
Koninklijke Philips and related stocks such as ZimVie Inc, Stryker, and Boston Scientific Corp Ebitda description
My Equities
My Current Equities and Potential Positions
Koninklijke Philips NV | PHG |
Classification | Electrical Equipment |
Location | Netherlands |
Exchange | New York Stock Exchange |
USD 26.38
Check out Koninklijke Philips Performance and Koninklijke Philips Correlation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Koninklijke Philips technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.